GCKR: A Promising Drug Target for Cellular Signaling and Disease

Target Name: GCKR

NCBI ID: G2646

GCKR

GCKR: A Promising Drug Target for Cellular Signaling and Disease

GCKR (G protein-coupled receptor) is a protein that is expressed in many different tissues throughout the body. It is a member of the G protein-coupled receptor family, which is a large family of transmembrane proteins that play a key role in cellular signaling. G protein-coupled receptors are involved in a wide range of physiological processes, including sensory perception, neurotransmission, and hormone signaling.

One of the key features of GCKR is its role in cell signaling. It is a critical receptor for the neurotransmitter Substance P, which is involved in pain perception and neurotransmission. When Substance P binds to GCKR, it triggers a signaling cascade that involves the activation of several different signaling pathways. These pathways can lead to changes in gene expression, protein synthesis, and other cellular processes.

GCKR is also involved in the regulation of cellular signaling by hormones. For example, it is a critical receptor for the hormone Insulin, which is involved in regulating blood sugar levels. When Insulin binds to GCKR, it can trigger a signaling cascade that involves the activation of several different signaling pathways. These pathways can lead to changes in gene expression, protein synthesis, and other cellular processes.

In addition to its role in cell signaling, GCKR is also potential drug target. The FGQTL5 gene, which encodes for GCKR, has been identified as a potential drug target for several different diseases. For example, studies have shown that inhibiting FGQTL5 has potential therapeutic benefits for a variety of conditions, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the potential reasons why GCKR is a promising drug target is its structure. GCKR is a large protein that is involved in several different signaling pathways. This makes it a likely candidate for drug targeting. Additionally, its structure allows researchers to study its function at the molecular level, which is important for understanding how it works and how it can be targeted.

Another potential reason why GCKR is a promising drug target is its role in disease. Many diseases are characterized by the overuse or underuse of certain hormones or signaling pathways. GCKR is involved in the regulation of a wide range of hormones and signaling pathways, which makes it a potential target for diseases that are characterized by these processes. For example, some diseases are characterized by the overuse of insulin or other hormones. By targeting GCKR, researchers may be able to develop new treatments for these diseases.

In conclusion, GCKR is a protein that is involved in a wide range of cellular signaling processes. It is a potential drug target for several different diseases due to its structure and its role in the regulation of hormones and signaling pathways. Further research is needed to fully understand its function and potential as a drug target.

Protein Name: Glucokinase Regulator

Functions: Regulates glucokinase (GCK) by forming an inactive complex with this enzyme (PubMed:23621087, PubMed:23733961). Acts by promoting GCK recruitment to the nucleus, possibly to provide a reserve of GCK that can be quickly released in the cytoplasm after a meal (PubMed:10456334). The affinity of GCKR for GCK is modulated by fructose metabolites: GCKR with bound fructose 6-phosphate has increased affinity for GCK, while GCKR with bound fructose 1-phosphate has strongly decreased affinity for GCK and does not inhibit GCK activity (PubMed:23621087, PubMed:23733961)

The "GCKR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GCKR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets